Qingdao Baheal Medical Inc
SZSE:301015
Qingdao Baheal Medical Inc
Tax Provision
Qingdao Baheal Medical Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Q
|
Qingdao Baheal Medical Inc
SZSE:301015
|
Tax Provision
-¥233.7m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
Sinopharm Group Co Ltd
HKEX:1099
|
Tax Provision
-¥4.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-16%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Tax Provision
-¥1.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-11%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Tax Provision
-¥715.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-18%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Tax Provision
-¥591.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-19%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Tax Provision
-¥638.2m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-11%
|
See Also
What is Qingdao Baheal Medical Inc's Tax Provision?
Tax Provision
-233.7m
CNY
Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Tax Provision amounts to -233.7m CNY.
What is Qingdao Baheal Medical Inc's Tax Provision growth rate?
Tax Provision CAGR 5Y
-23%
Over the last year, the Tax Provision growth was -28%. The average annual Tax Provision growth rates for Qingdao Baheal Medical Inc have been -36% over the past three years , -23% over the past five years .